Abstract
Hybrid PET/MRI represents an innovative diagnostic technology for non-invasive in vivo imaging of cancer. Although the current clinical experience is limited to few clinical centres investing in such an ambitious technology, preliminary results are showing potentials for hybrid PET/MRI to enter in the clinical setting as imaging technology that can profoundly impact on the pool of available in vivo multimodal imaging studies. The higher contrast increases detectability of oncological lesions in specific applications; the reduction of radiation exposure leads benefits for children and young adults and for follow-up studies; the multi-functionality of PET/MRI opens up to several opportunities for assessing cancer disease and for addressing oncological patients to optimal care.
| Original language | English |
|---|---|
| Pages (from-to) | 106-117 |
| Number of pages | 12 |
| Journal | Current Hypertension Reviews |
| Volume | 12 |
| Issue number | 2 |
| Publication status | Published - May 1 2016 |
| Externally published | Yes |
Fingerprint
Keywords
- Clinical PET/MRI
- Hybrid imaging
- MRI nanotechnology application
- Multi-parametric MRI
- Oncology
- PET
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
Cite this
Hybrid PET/MRI for in Vivo imaging of cancer : Current clinical experiences and recent advances. / Castiglioni, Isabella; Gallivanone, Francesca; Canevari, Carla.
In: Current Hypertension Reviews, Vol. 12, No. 2, 01.05.2016, p. 106-117.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Hybrid PET/MRI for in Vivo imaging of cancer
T2 - Current clinical experiences and recent advances
AU - Castiglioni, Isabella
AU - Gallivanone, Francesca
AU - Canevari, Carla
PY - 2016/5/1
Y1 - 2016/5/1
N2 - Hybrid PET/MRI represents an innovative diagnostic technology for non-invasive in vivo imaging of cancer. Although the current clinical experience is limited to few clinical centres investing in such an ambitious technology, preliminary results are showing potentials for hybrid PET/MRI to enter in the clinical setting as imaging technology that can profoundly impact on the pool of available in vivo multimodal imaging studies. The higher contrast increases detectability of oncological lesions in specific applications; the reduction of radiation exposure leads benefits for children and young adults and for follow-up studies; the multi-functionality of PET/MRI opens up to several opportunities for assessing cancer disease and for addressing oncological patients to optimal care.
AB - Hybrid PET/MRI represents an innovative diagnostic technology for non-invasive in vivo imaging of cancer. Although the current clinical experience is limited to few clinical centres investing in such an ambitious technology, preliminary results are showing potentials for hybrid PET/MRI to enter in the clinical setting as imaging technology that can profoundly impact on the pool of available in vivo multimodal imaging studies. The higher contrast increases detectability of oncological lesions in specific applications; the reduction of radiation exposure leads benefits for children and young adults and for follow-up studies; the multi-functionality of PET/MRI opens up to several opportunities for assessing cancer disease and for addressing oncological patients to optimal care.
KW - Clinical PET/MRI
KW - Hybrid imaging
KW - MRI nanotechnology application
KW - Multi-parametric MRI
KW - Oncology
KW - PET
UR - http://www.scopus.com/inward/record.url?scp=84961589869&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84961589869&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84961589869
VL - 12
SP - 106
EP - 117
JO - Current Hypertension Reviews
JF - Current Hypertension Reviews
SN - 1573-4021
IS - 2
ER -